ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE: STJ) today announced that it has distributed a programmer software upgrade to eliminate a random, low-frequency anomaly that could affect ventricular sensing in the Epic™ and Atlas™ families of implantable cardiac defibrillators.
